Evaluation of the New Acceleromyograph TOF 3D
Evaluation of the New Three-dimensional Acceleromyograph TOF 3D Compared With the Established TOF Watch SX.
1 other identifier
interventional
50
1 country
1
Brief Summary
The TOF 3D is a new acceleromyograph designed to assess the degree of a neuromuscular block during anesthesia. The study compares the new three-dimensional technique with the established TOF Watch SX.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 2, 2021
CompletedFirst Posted
Study publicly available on registry
August 13, 2021
CompletedStudy Start
First participant enrolled
August 31, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2022
CompletedMarch 31, 2022
March 1, 2022
1 year
August 2, 2021
March 30, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
TOF-R 90%
Difference of the 90% train-of-four (TOF) recovery time between both devices
12 months
Secondary Outcomes (2)
repeatability (precision)
12 months
bias and limits of agreement (Bland-Altman analysis)
12 months
Study Arms (2)
adductor pollicis AP
EXPERIMENTALMeasurement site: M.adductor pollicis of both arms.
Corrugator supercilii CS
EXPERIMENTALMeasurement site: M. corrugator supercilii at both sides
Interventions
Simultaneous measurement of the time course of a neuromuscular block with 2 acceleromyographs
Eligibility Criteria
You may qualify if:
- Patients undergoing elective gynecologic surgery requiring general anesthesia and neuromuscular block
You may not qualify if:
- anticipated difficult airway
- Risk of pulmonary aspiration
- acute infection
- pregnancy
- renal or hepatic insufficiency
- neuromuscular disease
- chronic intake of drugs influencing neuromuscular block
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
KKH Dormagen
Dormagen, D-41540, Germany
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof. Dr. Stefan Soltesz
Study Record Dates
First Submitted
August 2, 2021
First Posted
August 13, 2021
Study Start
August 31, 2021
Primary Completion
August 31, 2022
Study Completion
August 31, 2022
Last Updated
March 31, 2022
Record last verified: 2022-03
Data Sharing
- IPD Sharing
- Will not share